LONDON, Sept. 30, 2021 (GLOBE NEWSWIRE) — According to The Business Research Company's research report on the alpha mannosidosis market, the market is supported by high investments, government initiatives for infrastructure development and research, and an increase in disposable incomes.
The global alpha mannosidosis market is expected to grow from $7.50 million in 2020 to $8.89 million in 2021 at a compound annual growth rate (CAGR) of 18.6%. The growth is mainly due to increasing prevalence of alpha mannosidosis, use of orphan drugs, fee reductions and tax credits, increasing investment in the rare disease treatment and advancements in treatment drugs. The alpha mannosidosis market is expected to reach $17.91 million in 2025 at a CAGR of 19.1%.
The global alpha mannosidosis market is highly concentrated, with only a few players in the market. One company in the market made up to 89.20% of the total market in 2020. Major players in the market include Chiesi Farmaceutici S.p.A., Nuo Therapeutics, and Zymenex.
North America is the largest region in the alpha mannosidosis market. It is followed by Western Europe, Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the alpha mannosidosis market will be Asia Pacific and Western Europe where growth will be at CAGRs of 38.1% and 14.0% respectively during 2025-2030.
The Business Research Company's report titled Alpha Mannosidosis Global Market Report 2021 – By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy), By Indication (Type I, Type II, Type III), By End-User (Hospitals, Specialty Clinics), COVID-19 Growth And Change covers major alpha mannosidosis companies, alpha mannosidosis market share by company, alpha mannosidosis manufacturers, alpha mannosidosis market size, and alpha mannosidosis market forecasts. The report also covers the global alpha mannosidosis market and its segments.
Request For A Sample Of The Global Alpha Mannosidosis Market Report:
<a href="https://www.globenewswire.com/Tracker?data=JsjKaEfLX-igyFGX0uWNuBtGjp-aWNhXDmeqoVGsXefHiUsC4QMo6hWrsdRxz_Ma7UJqG8RymOnCg9MR1TgAikmK_ZuAd1mxMHmFvL6sL6bNPzmeX3KRa3yP9uPhy3xvOr__Eah8MHM3srIp-7MKeAZ8YMT4Rk14rwzyA53IqVmbfpZZ9WEanZXBFmh0ov6x9BaXntOZo-RKmjH6aMmWwyIuJfbK7zfRBEfeM7Q8K5g=" …
Full story available on Benzinga.com